Latest Diabetes News
Decrease in length of stay and mortality, but increase in mean hospital charges during study period.
Women with type 2 diabetes have a 1.5-fold higher risk of renal cell carcinoma compared with non-diabetic women.
Frequency of primary outcome was 27.6 and 23.4% in glyburide and insulin groups, respectively.
Major adverse CV and cerebrovascular events with noncardiac sx have also increased in DM patients
Aortic distensibility independently linked to concentric left ventricular remodeling
Breakfast time mediates the association between morning-evening preference and BMI
Overall, 21, 29, and 13% meet goals for fruit, vegetable, and dairy intake, respectively
Increased risk of CVD for achieved systolic blood pressure of 120 versus 130 or 140 mm Hg
In a study of patients with type 2 diabetes, researchers observed a significantly lower annual decline in estimated glomerular filtration rate among those treated with fenofibrates vs placebo.
In a survey, nearly one-third of hemodialysis patients said they disliked fluid restriction.
Among adults with heart disease, risk increased with DPP-4I vs thiazolidinedione not sulfonylureas
DM tied to 6-month mortality, major complications, ICU admission, mechanical ventilation, LOS
10-year lifestyle, weight loss changes increased disability-free years in women, those without CVD
Higher risk of inflammatory bowel disease with longer use of dipeptidyl peptidase-4 inhibitor
AKI hospitalizations were 4 times more likely among patients with diabetes.
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)
Renal and Urology News Articles
- Novel Blood Test Improves Detection of High-Grade Prostate Cancer
- Stone Composition Affects Nephrolithiasis Recurrence Rate
- Ultrasound Still Underused for Initial Imaging of Acute Renal Colic
- Hyperkalemia Drug Receives FDA Approval
- Post-op Intravesical Gemcitabine May Lower Bladder CA Recurrence Risk